Cumming School of Medicine
The Arnie Charbonneau Cancer Institute is a community of researchers and educators dedicated to achieving a cancer-free future. Charbonneau is meeting the cancer challenge through discovery and innovation in basic and applied research. The Institute brings together scientists and physicians to integrate research and care across disciplines – from understanding and preventing cancer, to transforming its detection and treatment, to improving life with and after cancer. Our members include researchers at the Tom Baker Cancer Centre and the University of Calgary’s Cumming School of Medicine and Teaching Hospitals. Learn more about how we are moving forward.
A new study from Dr. Daniel Heng, clinical associate at the Arnie Charbonneau Cancer Institute and Department of Oncology has shown that men with metastatic testicular cancer who are disease-free two years after dignosis and treatment have a cure rate of 98 percent. For this work Dr. Danny Heng has been awarded the prestigious Cumming School of Medicine’s Research (Clinical)Award for clinical, adjunct, and research faculty.